Overlooked and Underdiagnosed
Despite established guidelines, testing for CS remains underutilized in patients with unexplained VT/VF. This diagnostic gap contributes significantly to the lower prevalence of CS (1.4%) than the expected 17% to 28% in this cohort and suggests an area for improvement.
Authors
- Paari Dominic (ORCID: https://orcid.org/0000-0002-7843-375X)
- Aaron Sifuentes
- Ghazaleh Goldar
- Mohammed Mhanna (ORCID: https://orcid.org/0000-0003-1443-7177)
- Peter Farjo (ORCID: https://orcid.org/0000-0002-0125-610X)
- Kaushik Gokul
- Usamah M ElBakkush
Institutions
- University of Iowa Hospitals and Clinics (US)
- Wake Forest University (US)
Publication Details
- Journal
- JACC Advances
- Published
- 2025-10-28
- DOI
- https://doi.org/10.1016/j.jacadv.2025.102246
- Primary Topic
- Fibromyalgia and Chronic Fatigue Syndrome Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00